Skip to main content
. 2021 Apr 9;21:382. doi: 10.1186/s12885-021-08117-8

Table 2.

Separate comparison of surgical data and postoperative outcomes

Variable LDP (n = 86) ODP (n = 86) p value LPD (n = 101) OPD (n = 101) p value
Operative time (min)a 189.1 ± 45.2 213.3 ± 54.4 < 0.01 416.2 ± 78.8 365.0 ± 81.6 < 0.01
Estimated blood loss (mL)b 180 (80–600) 220 (120–800) < 0.01 250 (150–900) 300 (180–1000) 0.04
RBC transfusion (%) 3 (3.5%) 10 (11.6%) 0.04 14 (13.9%) 22 (21.8%) 0.14
Postoperative hospital stay (days)b 9 (4–34) 13 (7–42) < 0.01 14 (9–69) 18 (11–52) < 0.01
Overall morbidity (n, %) 8 (9.3%) 14 (16.3%) 0.17 22 (21.8%) 32 (31.7%) 0.11
CR-POPF 5 7 12 16
DGE (Grade A/ Grade B, C) 0 (0/0) 3 (2/1) 6 (4/2) 10 (5/5)
PPH (Grade A/ Grade B, C) 0 (0/0) 2 (1/1) 5 (1/4) 6 (3/3)
Bile leak 0 0 2 3
Wound infection 0 2 1 1
Lymphorrhea 1 0 0 2
Pulmonary complications 2 2 2 5
Reoperation (%) 0 0 1.00 6 (5.9%) 8 (7.9%) 0.58
Clavien-Dindo classification 0.33 0.42
I-II 4 (4.7%) 5 (5.6%) 10 (9.9%) 16 (15.8%)
III-IV 4 (4.7%) 9 (10.5%) 11 (10.9%) 15 (14.9%)
V (90-day mortality) 0 (0%) 0 (0%) 1 (1.0%) 1 (1.0%)
Adjuvant treatment (%) 61 (70.9%) 57 (66.3%) 0.51 67 (66.3%) 65 (64.4%) 0.77
Time to adjuvant treatment (days)a 50 (28–82) 52 (26–88) 0.14 59 (26–98) 60 (26–103) 0.68

a: values were showed as mean (standard deviation) and tested by Student’s t test; b: values were showed median (range) and tested by Mann-Whitney U test